AAAAAA
Results: 1-25/30
Authors:
LANCTOT KL
BEST TS
MITTMANN N
LIU BA
OH PI
EINARSON TR
NARANJO CA
Citation: Kl. Lanctot et al., EFFICACY AND SAFETY OF NEUROLEPTICS IN BEHAVIORAL-DISORDERS ASSOCIATED WITH DEMENTIA, The Journal of clinical psychiatry, 59(10), 1998, pp. 550-561
Authors:
LANCTOT KL
HERRMANN N
ERYAVEC G
VANREEKUM R
SHULMAN RW
NARANJO CA
Citation: Kl. Lanctot et al., CENTRAL SEROTONERGIC (5-HT) FUNCTION IS RELATED TO AGITATED AGGRESSION IN ALZHEIMERS-DISEASE (AD), Clinical pharmacology and therapeutics, 63(2), 1998, pp. 59-59
DIFFERENTIAL-EFFECTS OF AGING ON RESPONSE TO PROBES OF THE PERIPHERALAND CENTRAL CHOLINERGIC SYSTEMS
Authors:
FOURIE J
NARANJO CA
HERRMANN N
LANCTOT KL
BIRT C
Citation: J. Fourie et al., DIFFERENTIAL-EFFECTS OF AGING ON RESPONSE TO PROBES OF THE PERIPHERALAND CENTRAL CHOLINERGIC SYSTEMS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 60-60
Authors:
LANCTOT KL
RISEBROUGH N
OH PI
Citation: Kl. Lanctot et al., COGNITIVE ENHANCERS IN ALZHEIMERS-DISEASE - WORTHWHILE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 92-92
Authors:
OH P
SONI J
RISEBROUGH N
BREMNER KE
LANCTOT KL
NARANJO CA
Citation: P. Oh et al., ECONOMIC-EVALUATION OF RISPERIDONE (R) IN THE TREATMENT OF SCHIZOPHRENIA (SCZ), Clinical pharmacology and therapeutics, 63(2), 1998, pp. 93-93
Authors:
MOSS JH
LANCTOT KL
Citation: Jh. Moss et Kl. Lanctot, IATROGENIC BENZODIAZEPINE WITHDRAWAL DELIRIUM IN HOSPITALIZED OLDER PATIENTS, Journal of the American Geriatrics Society, 46(8), 1998, pp. 1020-1022
Authors:
HERRMANN N
LANCTOT KL
Citation: N. Herrmann et Kl. Lanctot, FROM TRANSMITTERS TO TREATMENT - THE PHARMACOTHERAPY OF BEHAVIORAL DISTURBANCES IN DEMENTIA, Canadian journal of psychiatry, 42, 1997, pp. 51-64
Authors:
MITTMANN N
HERRMANN N
EINARSON TR
BUSTO UE
LANCTOT KL
LIU BA
SHULMAN KI
SILVER IL
NARANJO CA
SHEAR NH
Citation: N. Mittmann et al., THE EFFICACY, SAFETY AND TOLERABILITY OF ANTIDEPRESSANTS IN LATE-LIFEDEPRESSION - A METAANALYSIS, Journal of affective disorders, 46(3), 1997, pp. 191-217
Authors:
LANCTOT KL
HERRMANN N
NARANJO CA
VANREEKUM R
ERYAVEC G
SHULMAN RW
Citation: Kl. Lanctot et al., ROLE OF SEROTONIN IN AGGRESSIVE BEHAVIORS ASSOCIATED WITH ALZHEIMERS-DISEASE - PRELIMINARY-RESULTS, Psychopharmacology bulletin, 33(3), 1997, pp. 545-545
Authors:
LANCTOT KL
OH PI
HERRMANN N
LIU BA
Citation: Kl. Lanctot et al., ECONOMIC APPRAISAL OF PHARMACOLOGICAL THERAPY FOR BEHAVIORAL-DISORDERS IN DEMENTIA, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 34-34
Authors:
HERRMANN N
LANCTOT KL
NARANJO CA
Citation: N. Herrmann et al., BEHAVIORAL-DISORDERS IN DEMENTED ELDERLY PATIENTS - CURRENT ISSUES INPHARMACOTHERAPY, CNS DRUGS, 6(4), 1996, pp. 280-300
Authors:
LANCTOT KL
HERRMANN N
BOWLES S
BEST T
NARANJO CA
Citation: Kl. Lanctot et al., ASSESSING THE ROLE OF DRUGS IN BEHAVIORAL-DISORDERS ASSOCIATED WITH DEMENTIA USING A BAYESIAN-APPROACH, Psychopharmacology bulletin, 32(3), 1996, pp. 472-472
Authors:
LANCTOT KL
KWOK MCO
BUSTO U
NARANJO CA
Citation: Kl. Lanctot et al., BAYESIAN EVALUATION OF SPONTANEOUS REPORTS OF PANCREATITIS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 4-4
Authors:
LANCTOT KL
TURKSEN IB
BAZOON M
NARANJO CA
Citation: Kl. Lanctot et al., EVALUATION OF ADVERSE DRUG EVENTS USING FUZZY-REASONING - A NOVEL-APPROACH, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 5-5
Authors:
BRADLEY CA
ISKEDJIAN M
LANCTOT KL
MITTMANN N
SIMONE C
STPIERRE E
MILLER E
BLATMAN B
CHABURSKY B
EINARSON TR
Citation: Ca. Bradley et al., QUALITY ASSESSMENT OF ECONOMIC EVALUATIONS IN SELECTED PHARMACY, MEDICAL, AND HEALTH ECONOMICS JOURNALS, The Annals of pharmacotherapy, 29(7-8), 1995, pp. 681-689
Authors:
NARANJO CA
POULOS CX
LANCTOT KL
BREMNER KE
KWOK M
UMANA M
Citation: Ca. Naranjo et al., RITANSERIN, A CENTRAL 5-HT2 ANTAGONIST, IN HEAVY SOCIAL DRINKERS - DESIRE TO DRINK, ALCOHOL INTAKE AND RELATED EFFECTS, Addiction, 90(7), 1995, pp. 893-905
EFFECTS OF CITALOPRAM AND BRIEF PSYCHOSOCIAL INTERVENTION ON ALCOHOL INTAKE, DEPENDENCE AND PROBLEMS
Authors:
NARANJO CA
BREMNER KE
LANCTOT KL
Citation: Ca. Naranjo et al., EFFECTS OF CITALOPRAM AND BRIEF PSYCHOSOCIAL INTERVENTION ON ALCOHOL INTAKE, DEPENDENCE AND PROBLEMS, Addiction, 90(1), 1995, pp. 87-99
Authors:
LANCTOT KL
NARANJO CA
Citation: Kl. Lanctot et Ca. Naranjo, COMPARISON OF THE BAYESIAN-APPROACH AND A SIMPLE ALGORITHM FOR ASSESSMENT OF ADVERSE DRUG EVENTS, Clinical pharmacology and therapeutics, 58(6), 1995, pp. 692-698
Authors:
LANCTOT KL
BOWLES S
HERRMANN N
NARANJO CA
Citation: Kl. Lanctot et al., IDENTIFYING DRUG-INDUCED BEHAVIORAL-DISORDERS IN DEMENTIA - A NEW DIAGNOSTIC-APPROACH, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 136-136
Authors:
LANCTOT KL
MITTMANN N
LIU B
BEST T
OH PI
EINARSON TR
NARANJO CA
Citation: Kl. Lanctot et al., EFFICACY AND SAFETY OF NEUROLEPTICS IN BEHAVIORAL-DISORDERS ASSOCIATED WITH DEMENTIA, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 199-199
Authors:
LIU BA
MITTMANN N
LANCTOT KL
OH PI
EINARSON TR
SHEAR NH
Citation: Ba. Liu et al., BENZODIAZEPINES AND FALLS IN THE ELDERLY - A METAANALYSIS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 200-200
Authors:
NARANJO CA
POULOS CX
BREMNER KE
LANCTOT KL
Citation: Ca. Naranjo et al., FLUOXETINE ATTENUATES ALCOHOL INTAKE AND DESIRE TO DRINK, International clinical psychopharmacology, 9(3), 1994, pp. 163-172
Authors:
LANCTOT KL
NARANJO CA
Citation: Kl. Lanctot et Ca. Naranjo, COMPUTER-ASSISTED EVALUATION OF ADVERSE EVENTS USING A BAYESIAN-APPROACH, Journal of clinical pharmacology, 34(2), 1994, pp. 142-147
Authors:
LANCTOT KL
GHAJAR BM
SHEAR NH
NARANJO CA
Citation: Kl. Lanctot et al., IMPROVING THE DIAGNOSIS OF HYPERSENSITIVITY REACTIONS ASSOCIATED WITHSULFONAMIDES, Journal of clinical pharmacology, 34(12), 1994, pp. 1228-1233
Authors:
NARANJO CA
KWOK MCO
LANCTOT KL
ZHAO HP
SPIELBERG SP
SHEAR NH
Citation: Ca. Naranjo et al., ENHANCED DIFFERENTIAL-DIAGNOSIS OF ANTICONVULSANT HYPERSENSITIVITY REACTIONS BY AN INTEGRATED BAYESIAN AND BIOCHEMICAL APPROACH, Clinical pharmacology and therapeutics, 56(5), 1994, pp. 564-575